Innovating early detection

In 2023, the CDC reported that approximately 1 in 36 children in the U.S. is diagnosed with an autism spectrum disorder (ASD), according to 2020 data. Boys are four times more likely to be diagnosed with autism than girls. We partner with Hospitals and Universities to jointly pursue NIH and NSF grants to fund research to develop IP, medical devices, and software innovations capable of screening for multiple developmental differences in newborns in a single 60-second test.

Parents of non-neurotypical infants can face many challenges. mHealthcare is committed to providing Parents that receive a positive diagnosis with critical school systems information, financial support tools, and therapeutic care options. You are not in this alone!

Federal Grants and 501c(3) partnerships for research

mHealthcare seeks federal grants, corporate donations, and small-dollar individual support to fund research to identify biomarkers for detecting developmental differences as early as the first three months of life.